BioCentury
ARTICLE | Company News

Mallinckrodt to acquire Ikaria for $2.3B

March 6, 2015 2:27 AM UTC

Mallinckrodt plc (NYSE:MNK) will acquire Ikaria Inc. (Hampton, N.J.) for $2.3 billion from an investor group led by private equity firm Madison Dearborn Partners.

Ikaria markets INOmax inhaled nitric oxide to treat hypoxic respiratory failure in term and near-term infants. The company also markets Lucassin terlipressin, a synthetic analog of lysine- vasopressin, outside the U.S. to treat Type I hepatorenal syndrome (HRS). ...